Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS
· Delayed Price · Currency is USD
0.3090
0.00 (0.00%)
At close: Dec 5, 2025
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $1.43 million as of December 5, 2025. Its market cap has decreased by -51.34% in one year.
Market Cap
1.43M
Enterprise Value
-163.85K
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.31
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 1.43M, a decrease of -94.72%. That is a compound annual growth rate of -62.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.43M | -61.28% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 503.27M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 359.36M |
| Silence Therapeutics | 295.21M |
| Nika Pharmaceuticals | 259.91M |